Do we need individualised prescribing quality assessment? The case of diabetes treatment

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Clinical Pharmacy

• Publication date

  2011-01-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11096-010-9471-0PMID 21744186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The path to personalized medicine.

  2010cited by this paper
• A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management

  2010cited by this paper
• Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts.

  2010cited by this paper
• Quality Measurement in Diabetes Care

  2009cited by this paper
• Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany.

  2009cited by this paper
• Inappropriate Medication Use and Prescribing Indicators in Elderly Australians

  2008influential reference
• Perceptions of Quality‐of‐Life Effects of Treatments for Diabetes Mellitus in Vulnerable and Nonvulnerable Older Patients

  2008cited by this paper
• Development of Clinical Indicators for Type 2 Diabetes

  2008cited by this paper
• Benchmarking physician performance: reliability of individual and composite measures.

  2008cited by this paper
• Cross-Sectional Versus Sequential Quality Indicators of Risk Factor Management in Patients with Type 2 Diabetes

  2008cited by this paper
• Individualising Therapy for Older Adults with Diabetes Mellitus

  2007cited by this paper
• Quality Indicators for the Care of Diabetes Mellitus in Vulnerable Elders

  2007cited by this paper
• Patterns of prevalent major chronic disease among older adults in the United States.

  2007cited by this paper
• Introduction to the Assessing Care of Vulnerable Elders‐3 Quality Indicator Measurement Set

  2007cited by this paper
• Comparison of Administrative Data and Medical Records to Measure the Quality of Medical Care Provided to Vulnerable Older Patients

  2006cited by this paper
• Using clinical guidelines designed for older adults with diabetes mellitus and complex health status.

  2006cited by this paper
• Selección de indicadores de calidad de prescripción en atención primaria mediante un grupo de consenso

  2006cited by this paper
• [Selection of quality indicators for primary care prescription through a consensus group].

  2006cited by this paper
• Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.

  2005cited by this paper
• Self‐Reported Goals of Older Patients with Type 2 Diabetes Mellitus

  2005cited by this paper
• Developing quality indicators for older adults: transfer from the USA to the UK is feasible

  2004cited by this paper
• Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

  2003cited by this paper
• Guidelines for Improving the Care of the Older Person with Diabetes Mellitus

  2003cited by this paper
• Guidelines for improving the care of the older person with diabetes mellitus.

  2003cited by this paper
• Guidelines for Improving the Care of the Older Person with Diabetes Mellitus

  2003influential reference
• Prescribing indicators and their use by primary care groups to influence prescribing

  2002cited by this paper
• Auditing prescription practice using explicit criteria and computerized drug benefit claims data.

  1997cited by this paper
• 30% of HMOs reviewed earn full accreditation--NCQA (National Committee for Quality Assurance)

  1994cited by this paper

• Health promotion interventions in type 2 diabetes.

  2015cites this paper